Verdence Capital Advisors LLC lowered its position in CME Group Inc. (NASDAQ:CME – Free Report) by 13.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,714 shares of the financial services provider’s stock after selling 853 shares during the period. Verdence Capital Advisors LLC’s holdings in CME Group were worth $1,575,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its holdings in CME Group by 1.2% in the first quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider’s stock valued at $9,190,661,000 after acquiring an additional 400,737 shares during the period. Raymond James Financial Inc. lifted its holdings in CME Group by 9.7% in the first quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider’s stock valued at $1,091,401,000 after acquiring an additional 363,130 shares during the period. Vontobel Holding Ltd. lifted its holdings in CME Group by 3.0% in the second quarter. Vontobel Holding Ltd. now owns 2,920,046 shares of the financial services provider’s stock valued at $804,823,000 after acquiring an additional 84,005 shares during the period. Massachusetts Financial Services Co. MA lifted its holdings in CME Group by 29.9% in the first quarter. Massachusetts Financial Services Co. MA now owns 2,818,590 shares of the financial services provider’s stock valued at $747,744,000 after acquiring an additional 648,591 shares during the period. Finally, AQR Capital Management LLC lifted its holdings in CME Group by 10.3% in the first quarter. AQR Capital Management LLC now owns 2,783,759 shares of the financial services provider’s stock valued at $735,539,000 after acquiring an additional 260,065 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on CME shares. Weiss Ratings reissued a “buy (b)” rating on shares of CME Group in a report on Wednesday, October 8th. Raymond James Financial reduced their target price on CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a research note on Monday. Jefferies Financial Group reduced their target price on CME Group from $313.00 to $304.00 and set a “buy” rating for the company in a research note on Friday. TD Cowen upped their target price on CME Group from $281.00 to $288.00 and gave the stock a “hold” rating in a research note on Wednesday, October 8th. Finally, JPMorgan Chase & Co. upped their target price on CME Group from $246.00 to $252.00 and gave the stock an “underweight” rating in a research note on Thursday, September 25th. Seven analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $283.43.
CME Group Stock Down 0.1%
NASDAQ CME opened at $271.28 on Tuesday. The business has a fifty day moving average price of $268.57 and a 200 day moving average price of $271.35. CME Group Inc. has a one year low of $213.94 and a one year high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market cap of $97.76 billion, a P/E ratio of 26.26, a P/E/G ratio of 5.72 and a beta of 0.41.
CME Group (NASDAQ:CME – Get Free Report) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the business earned $2.56 EPS. Research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.8%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio is presently 48.40%.
Insiders Place Their Bets
In other news, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the transaction, the general counsel owned 7,851 shares of the company’s stock, valued at approximately $2,056,962. This represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is owned by company insiders.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- How to Use the MarketBeat Stock Screener
- FICO’s Big Dip Could Be the Best Buying Chance of the Year
- What is a Secondary Public Offering? What Investors Need to Know
- D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Datavault: A Speculative AI Play, But Beware of Volatility
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.